🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06432491
Recruiting Not applicable

The Association Between Core Temperature and Health

NCT06432491 · tracked via the Priya Life Science China tracker
Sponsor
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Phase
Not applicable
Started
2025-01-01
Last updated
2026-01-21

Condition(s) studied

Body Temperature ChangesBody CompositionAging

Investigational drug(s) / intervention(s)

Drinking cold water

Drinking cold water: Volunteers in the intervention group will be asked to drink up 500 ml 4℃ water within 10 minutes four times per day throughout the study.

Study summary

The goal of this clinical trial is to learn if cold water drinking could promote body composition and further extend healthy lifespan in Chinese older adults. The main questions it aims to answer are:

1. Does cold water drinking lower the body fat percentage?
2. Will cold water drinking positively extend lifespan in a long-term Researchers will compare cold water intervention group to a control group (drinking 37℃ water instead) to see if cold water drinking works to promote health and slow down ageing process.

Participants will:

1. Drink 4℃ or 37℃ water 4 times (9a.m., 12p.m., 15p.m., 18p.m.) every day for 6 months.
2. Visit the institute and health checkup department for tests and checkup at baseline, the end of the 3rd month, and the end of 6th month.

Eligibility

Sex
ALL
Min age
50 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Aged between 50 and 65 years old (including 50 and 65) * No surgery in the past 6 months * Healthy (No metabolic diseases, cardiovascular diseases, lung diseases (COPD, asthma, et al.), endocrine diseases and gastrointestinal diseases) * Based in Shenzhen during the whole study period * No significant change on body weight in the past 3 months Exclusion Criteria: * Those who need to take medication for a long term (including diet pills) * On a diet * Disabled * Females who are trying to get pregnant, pregnant, or breastfeeding * Presence of a metal implant in the body (e.g. pacemaker) * Those with claustrophobia * Those with blood phobia, pathological hypotension or hypertension * Those who are in other intervention studies

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Shenzhen Guangdong Recruiting

More Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06432491 on ClinicalTrials.gov ↗ ← All trials in China